Literature DB >> 23340833

The association between hepatitis B virus infection and disease activity, synovitis, or joint destruction in rheumatoid arthritis.

Chan-Juan Zou1, Lang-Jing Zhu, Yan-Hua Li, Ying-Qian Mo, Dong-Hui Zheng, Jian-Da Ma, Xia Ou-Yang, Frank Pessler, Lie Dai.   

Abstract

The prevalence of chronic hepatitis B virus (HBV) infection in China is high. Four percent of patients with HBV infection can present with polyarthritis and positive rheumatic factor similar to rheumatoid arthritis (RA). Here, we investigated the association between HBV infection and serological, radiological, or histological disease status in RA. According to HBV infection status, 223 consecutive hospitalized Chinese patients with RA were divided into the groups of chronic HBV infection, past HBV infection, and no HBV infection. Clinical data and hand radiographs were collected. Synovium was obtained by closed-needle biopsy, and serial tissue sections were stained immunohistochemically for HBV surface antigen (HBsAg) and cluster of differentiation (CD) markers. (1) The prevalence of HBsAg positivity and chronic hepatitis B in RA was consistent with the age-matched general Chinese population (11.2 vs. 8.7 %, 1.7 vs. 1.0 %, respectively, P > 0.05). (2) Clinical parameters, disease activity score in 28 joints, or Sharp scores showed no significant difference among the three groups in 206 RA or 140 treatment-naïve patients, both with active disease (all P > 0.05). (3) Synovial immunohistochemical staining showed negative HBsAg in ten RA patients with HBV carrier status and ten RA patients with past HBV infection. Except for higher subintimal CD3+ cell density in the past HBV infection group, Krenn's synovitis score, mean densities of subintima positive-staining cells (CD20, CD38, CD79a, and CD68), and CD34+ microvessel counts showed no significant difference among RA patients with HBV carrier status, past HBV infection, or no HBV infection (all P > 0.05). Chronic HBV infection may have no significant effect on disease activity, synovitis, or joint destruction in RA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23340833     DOI: 10.1007/s10067-013-2170-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  43 in total

Review 1.  Rheumatoid arthritis and hepatitis B virus: evaluating the pathogenic link.

Authors:  A Csepregi; E Nemesanszky; B Rojkovich; G Poor
Journal:  J Rheumatol       Date:  2001-03       Impact factor: 4.666

2.  Rapidly destructive knee arthropathy associated with hepatitis B.

Authors:  S Momohara; H Okamoto; N Tokita; T Tomatsu; N Kamatani
Journal:  Clin Exp Rheumatol       Date:  2006 Jan-Feb       Impact factor: 4.473

Review 3.  The molecular and cellular aspects of arthritis due to alphavirus infections: lesson learned from Ross River virus.

Authors:  Nestor E Rulli; Julian Melton; Anja Wilmes; Gary Ewart; Suresh Mahalingam
Journal:  Ann N Y Acad Sci       Date:  2007-04       Impact factor: 5.691

4.  Is screening for hepatitis necessary in diagnostic evaluation of rheumatoid arthritis in South Korea?

Authors:  Duck-An Kim; Think-You Kim
Journal:  J Rheumatol       Date:  2010-03       Impact factor: 4.666

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

Review 6.  The epidemiology of rheumatoid arthritis.

Authors:  S E Gabriel
Journal:  Rheum Dis Clin North Am       Date:  2001-05       Impact factor: 2.670

7.  A simplified disease activity index for rheumatoid arthritis for use in clinical practice.

Authors:  J S Smolen; F C Breedveld; M H Schiff; J R Kalden; P Emery; G Eberl; P L van Riel; P Tugwell
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

8.  Hepatitis B virus infection in patients with rheumatic diseases.

Authors:  H Permin; J Aldershvile; J O Nielsen
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

9.  Reactivation of hepatitis B.

Authors:  Jay H Hoofnagle
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

10.  The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders.

Authors:  Maya Ram; Juan-Manuel Anaya; Ori Barzilai; David Izhaky; Bat-Sheva Porat Katz; Miri Blank; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2008-07-09       Impact factor: 9.754

View more
  13 in total

Review 1.  Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

Authors:  Pilar López-Serrano; Elsa de la Fuente Briongos; Elisa Carrera Alonso; Jose Lázaro Pérez-Calle; Conrado Fernández Rodríguez
Journal:  World J Hepatol       Date:  2015-03-27

2.  Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in Taiwan.

Authors:  Ching-Sheng Hsu; Hui-Chu Lang; Kuang-Yung Huang; You-Chen Chao; Chien-Lin Chen
Journal:  Hepatol Int       Date:  2018-11-14       Impact factor: 6.047

3.  Nerolidol: a potential approach in rheumatoid arthritis through reduction of TNF-α, IL-1β, IL-6, NF-kB, COX-2 and antioxidant effect in CFA-induced arthritic model.

Authors:  Shanila Akhter; Hafiz Muhammad Irfan; Shah Jahan; Muhammad Shahzad; Muhammad Bilal Latif
Journal:  Inflammopharmacology       Date:  2022-02-25       Impact factor: 4.473

4.  Low positivity rates for HBeAg and HBV DNA in rheumatoid arthritis patients: a case-control study.

Authors:  Yue Jia; Jingjing Zhang; Lingfei Mo; Bomiao Ju; Nan Hu; Yanhua Wang; Pei Wang; Jie Zheng; Lan He; Jing Wang
Journal:  BMC Infect Dis       Date:  2022-06-24       Impact factor: 3.667

Review 5.  Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis.

Authors:  Jiang Su; Li Long; Kun Zou
Journal:  Clin Rheumatol       Date:  2018-04-10       Impact factor: 2.980

6.  Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice.

Authors:  Ying-Qian Mo; An-Qi Liang; Jian-Da Ma; Le-Feng Chen; Dong-Hui Zheng; H Ralph Schumacher; Lie Dai
Journal:  BMC Musculoskelet Disord       Date:  2014-12-22       Impact factor: 2.362

7.  Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies.

Authors:  Yu-Lan Chen; Jian-Zi Lin; Ying-Qian Mo; Jin-Jian Liang; Qian-Hua Li; Cheng-Jing Zhou; Xiu-Ning Wei; Jian-Da Ma; Ze-Hong Yang; Dong-Hui Zheng; Lie Dai
Journal:  PeerJ       Date:  2018-01-04       Impact factor: 2.984

8.  Association of Rheumatoid Arthritis and Hepatitis B Infection: A Nationwide Nested Case-Control Study From 1999 to 2009 in Taiwan.

Authors:  Ching-Sheng Hsu; Hui-Chu Lang; Kuang-Yung Huang; Hans Hsienhong Lin; Chien-Lin Chen
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

9.  Patients with Coexistence of Circulating Hepatitis B Surface Antigen and Its Antibody May Have a Strong Predisposition to Virus Reactivation During Immunosuppressive Therapy: A Hypothesis.

Authors:  Yu-Lan Chen; Ying-Qian Mo; Dong-Hui Zheng; Jian-Da Ma; Jun Jing; Lie Dai
Journal:  Med Sci Monit       Date:  2017-12-17

10.  HBsAb and HBcAb Have No Significant Effect on the Progression of SLE and RA.

Authors:  Fen Wang; Shujuan Lv; Jingyu Cai; Xianglian Zhou; Qicui Zhu; Jianhua Xu
Journal:  Iran J Public Health       Date:  2017-08       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.